Christine Turner


Christine Turner has represented issuers, private equity firms and investment banks on capital markets and corporate transactions, including initial public offerings, other equity offerings, high-yield and investment-grade debt offerings, acquisition financing and liability management transactions. Christine also counsels public companies with respect to general corporate and securities matters, including SEC reporting obligations and corporate governance.

Download full bio 


  • IGM Biosciences – $230 Million Follow-On Offering 

  • Doximity – $697 Million IPO 

  • FIGS – $668 Million IPO 

  • Treace Medical Concepts – $220 Million IPO 


  • Duke University School of Law
    JD, cum laude, 2015

  • Boston College
    BA, International Studies
    magna cum laude, 2010

Admissions & Credentials

New York



  • New York State Bar Association